oxymetholone has been researched along with methylprednisolone in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (20.00) | 18.7374 |
| 1990's | 4 (40.00) | 18.2507 |
| 2000's | 1 (10.00) | 29.6817 |
| 2010's | 3 (30.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Anasetti, C; Appelbaum, FR; Bryant, E; Buckner, CD; Doney, K; Pepe, M; Sanders, J; Singer, J; Storb, R; Sullivan, K | 1 |
| Appelbaum, FR; Buckner, CD; Deeg, HJ; Doney, K; McGuffin, R; Storb, R; Sullivan, KM; Thomas, ED; Witherspoon, R | 1 |
| Seip, M; Vidnes, J | 1 |
| Bacigalupo, A; Chaple, M; Chessells, J; Goldstone, AH; Hows, J; McCann, S; Milligan, D; Ottolander, J; Van Lint, MT; van't Veer, ET | 1 |
| Kagami, M; Kayashima, S; Kobari, S; Kondou, T; Watanabe, Y | 1 |
| Pavithran, K; Raji, NL; Thomas, M | 1 |
| Advani, SH; Gopal, R; Kulkarni, S; Nair, CN; Parikh, PM; Saikia, TK; Sastry, PS | 1 |
1 review(s) available for oxymetholone and methylprednisolone
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
3 trial(s) available for oxymetholone and methylprednisolone
| Article | Year |
|---|---|
Immunosuppressive therapy of aplastic anemia: results of a prospective, randomized trial of antithymocyte globulin (ATG), methylprednisolone, and oxymetholone to ATG, very high-dose methylprednisolone, and oxymetholone.
Topics: Adult; Anemia, Aplastic; Antilymphocyte Serum; Blood Transfusion; Bone Marrow Transplantation; Dose-Response Relationship, Drug; Female; Follow-Up Studies; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Immunosuppression Therapy; Male; Methylprednisolone; Oxymetholone; Probability; Prospective Studies; Time Factors | 1992 |
Treatment of aplastic anaemia (AA) with antilymphocyte globulin (ALG) and methylprednisolone (MPred) with or without androgens: a randomized trial from the EBMT SAA working party.
Topics: Adolescent; Adult; Aged; Anemia, Aplastic; Antilymphocyte Serum; Child; Child, Preschool; Drug Therapy, Combination; Female; Humans; Infant; Male; Methylprednisolone; Middle Aged; Oxymetholone; Retrospective Studies; Sex Factors | 1993 |
Antilymphocyte globulin (ALG) or antithymocyte globulin (ATG) with methylprednisone and oxymethalone in aplastic anaemia.
Topics: Adolescent; Adult; Anabolic Agents; Anemia, Aplastic; Anti-Inflammatory Agents; Antilymphocyte Serum; Child; Drug Therapy, Combination; Female; Humans; Immunosuppressive Agents; Male; Methylprednisolone; Middle Aged; Oxymetholone | 1997 |
6 other study(ies) available for oxymetholone and methylprednisolone
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Treatment of aplastic anemia with antithymocyte globulin, high-dose corticosteroids, and androgens.
Topics: Adult; Aged; Anemia, Aplastic; Antilymphocyte Serum; Dose-Response Relationship, Drug; Female; Humans; Immunosuppression Therapy; Methylprednisolone; Myelodysplastic Syndromes; Oxymetholone; T-Lymphocytes | 1987 |
Cyclosporine A in a case of refractory severe aplastic anaemia.
Topics: Anemia, Aplastic; Antilymphocyte Serum; Blood Transfusion; Child; Cyclosporins; Humans; Male; Methylprednisolone; Oxymetholone; Platelet Transfusion; Prednisone; Splenectomy; Thrombocytopenia | 1985 |
A patient with non-A, non-B, non-C hepatitis-associated aplastic anemia recovered promptly following immuno-suppressive therapy, including antithymocyte globulin.
Topics: Adult; Anemia, Aplastic; Antilymphocyte Serum; Autoimmune Diseases; Bone Marrow Cells; Combined Modality Therapy; Cyclosporine; Erythrocyte Transfusion; Glycyrrhizic Acid; Granulocyte Colony-Stimulating Factor; Hepatitis, Viral, Human; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Lymphocyte Subsets; Male; Methylprednisolone; Oxymetholone; Platelet Transfusion | 1998 |
Aplastic anemia complicating systemic lupus erythematosus--report of a case and review of the literature.
Topics: Adult; Anabolic Agents; Anemia, Aplastic; Blood Component Transfusion; Fatal Outcome; Female; Glucocorticoids; Humans; Lupus Erythematosus, Systemic; Methylprednisolone; Oxymetholone; Pancytopenia | 2002 |